ANTERIOS

ANTERIOS

Innovative biopharmaceutical solutions tackling the toughest health challenges with a focus on impactful treatments. Learn more
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$7.5m

Series A
N/A

$5.2m

Early VC
N/A

$1.5m

Early VC
N/A

$750k

Early VC
N/A

$2.0m

Early VC
N/A

$3.0m

Early VC
N/A

$4.7m

Early VC
N/A

N/A

IPO

$90.0m

Valuation: $90.0m

Acquisition
Total Funding$24.7m

Recent News about ANTERIOS

Edit
More about ANTERIOSinfo icon
Edit

Anterios Inc. operates in the biopharmaceutical industry, focusing on developing innovative treatments for some of the most challenging health conditions. The company serves a diverse range of clients, including healthcare providers, hospitals, and patients in need of advanced medical solutions. Anterios Inc. operates in a highly regulated market, adhering to stringent legal and ethical standards to ensure the safety and efficacy of its products. The business model is centered around research and development (R&D), where significant investments are made to discover and develop new drugs. Revenue is generated through the sale of these pharmaceutical products, licensing agreements, and partnerships with other healthcare organizations. The company aims to make a remarkable impact on people's lives by not only treating diseases but also improving overall health outcomes.

Keywords: biopharmaceutical, innovative treatments, healthcare providers, hospitals, patients, regulated market, R&D, drug discovery, licensing, health outcomes.